J

Jnaneshwar

Active Director Director DIN 08690172
DIN 08690172 First appointment Feb 2020 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value •••• Premium profile

About Jnaneshwar

Data last updated:

Jnaneshwar is a Director at Aartid Pharma Private Limited (since 2020). The company operates in Business Services. Aartid Pharma Private Limited reported revenue of ₹27 Lakh (FY 2022).

DIN 08690172
Primary Designation Director
Industry Business Services
First Appointment 05 Feb 2020
Oldest Company Age 6 yrs
Largest company Aartid Pharma Private Limited · ₹27 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aartid Pharma Private Limited U74900KA2020PTC132351
Director05 Feb 20202020₹27 Lakh (FY 2022)Active

Board colleagues of Jnaneshwar

NameDINCompanyDesignation
Sali Ningappa Priyanka08690173Aartid Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aartid Pharma Private Limited
Premium access

Shareholding and investment profile for Jnaneshwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jnaneshwar

Jnaneshwar currently holds 1 directorship: Aartid Pharma Private Limited (Director, since 05 Feb 2020, revenue ₹27 Lakh (FY 2022)).

Jnaneshwar was first appointed on 05 Feb 2020 as Director at Aartid Pharma Private Limited.

The current boards of Jnaneshwar's companies include Sali Ningappa Priyanka (Aartid Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available